Pharma Journalist -

Sharp Edge Labs, Inc., a drug discovery and development company focused on diseases involving defective protein trafficking, today announced that it has entered into a drug discovery…
Read More...

Drug firm Lupin has received final approval from the US health regulator to market cevimeline hydrochloride capsules, used for treatment of symptoms of dry mouth in patients with…
Read More...

Suven Life Sciences Ltd announces that the grant of one (1) product patent from Eurasia (025136) and one (1) product patent from Norway (339034) corresponding to the New Chemical…
Read More...

Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and…
Read More...

Ligand Pharmaceuticals announces it has entered into global license and supply agreements with Novartis for the development and commercialization of a Captisol-enabled oral liquid…
Read More...

Swiss company Genticel and Genkyotex have signed an agreement to enter into strategic combination. A portfolio of NADPH oxidase (NOX) oral small molecule inhibitors are being…
Read More...

Novo Nordisk has awarded Fluor an engineering, procurement, construction and construction management contract for its new $2bn diabetes Active Pharmaceutical Ingredient (API)…
Read More...

uniQure announced that its Board of Directors has unanimously approved the appointment of Matthew Kapusta as Chief Executive Officer (CEO) of the Company, effective immediately. Mr.…
Read More...

A jury in the US District Court for the District of Delaware ordered Gilead Sciences to pay $2.54bn in damages to Merck's subsidiary Idenix Pharmaceuticals for infringing its patents in…
Read More...

GSK is opening a new global vaccines research and development (R&D) center in Rockville, Maryland, US. Up to 200 new jobs will be created at the Rockville facility, with GSK…
Read More...